The Medical College of Georgia PLAY Project: Exercise Dose and Insulin Sensitivity in Obese Children
- Conditions
- ObesityType 2 Diabetes PreventionExecutive Function (Cognition)
- Interventions
- Behavioral: Aerobic exercise program
- Registration Number
- NCT00108901
- Brief Summary
The study is a behavioral clinical trial of aerobic exercise to determine dose-response effects on risk for type 2 diabetes, fatness, fitness, blood cholesterol levels, and other cardiovascular risk factors in overweight elementary schoolchildren.
The hypothesis is that the more exercise a child does, the more benefit he or she will gain in reducing the risk of diabetes and other cardiovascular diseases.
An ancillary study examined effects on cognition and achievement.
- Detailed Description
The study is a behavioral clinical trial of aerobic exercise to determine dose-response effects on insulin response to the oral glucose tolerance test, body composition, fitness, lipid profile, inflammation and other metabolic syndrome components in overweight elementary schoolchildren.
Blinded psychological assessments of cognition and achievement were obtained.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 222
- Overweight, sedentary children
- Black or white race
- Attending specific schools in Augusta, GA area from which this study is recruiting
- Unable to participate in testing or vigorous exercise program
- Diabetes
- Taking medication that would affect study results
- Sibling enrolled in project
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description High dose Aerobic exercise program This group was assigned to receive a 40 min/day aerobic exercise program offered 5 days/week after school. Families were offered a monthly healthy lifestyle class. Low Dose Aerobic exercise program This group was assigned to receive a 20 min/day aerobic exercise program offered 5 days/week after school. Families were offered a monthly healthy lifestyle class.
- Primary Outcome Measures
Name Time Method Insulin area under the curve (oral glucose tolerance test) 10-15 weeks Body composition (% body fat, visceral fat) 10-15 weeks Aerobic fitness 10-15 weeks Cognition (Executive function) 10-15 weeks
- Secondary Outcome Measures
Name Time Method Inflammation (C-reactive protein, fibrinogen) 10-15 weeks Glucose (oral glucose tolerance test) 10-15 weeks Lipid profile 10-15 weeks Blood pressure 10-15 weeks Academic achievement 10-15 weeks
Trial Locations
- Locations (1)
Georgia Prevention Institute, Medical College of Georgia
🇺🇸Augusta, Georgia, United States